Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions

Published:2022-12 Issue: Volume:240 Page:108231
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Jenkins Benjamin H.,Buckingham Josephine F.,Hanley Christopher J.,Thomas Gareth J.

Funder

Cancer Research UK

Pathological Society of Great Britain and Ireland

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference214 articles.

1. Pirfenidone reduces immune-suppressive capacity of cancer-associated fibroblasts through targeting CCL17 and TNF-beta;Aboulkheyr Es;Integrative Biology: Quantitative Biosciences from Nano to Macro,2020

2. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism;Adams;Cancer Research,2004

3. Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts;Albrengues;Nature Communications,2015

4. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer;Alvarez;British Journal of Cancer,2013

5. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression;Auciello;Cancer Discovery,2019

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma;The American Journal of Pathology;2024-08

2. Targeting ROS in cancer: rationale and strategies;Nature Reviews Drug Discovery;2024-07-09

3. FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma;Apoptosis;2024-06-02

4. Unraveling the prognostic significance of RGS gene family in gastric cancer and the potential implication of RGS4 in regulating tumor-infiltrating fibroblast;Frontiers in Molecular Biosciences;2024-04-17

5. Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy;Immunology;2024-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3